Tokyo, June 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061728) titled 'The efficacy of maxillary nerve block for postoperative pain relief after two-jaw orthognathic surgery: a prospective observational study' on June 1.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Open -but assessor(s) are blinded
Control - No treatment
Primary Sponsor:
Institute - others
Condition:
Condition - deformity of jaw
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To elucidate the efficacy of maxillary nerve block for postoperative pain relief after two-jaw orthognathic surgery
Basic objectives2 - Safety,Efficacy
Intervention:
Interventions/Control_1 - The participants in the intervention group receive maxillary nerve block with 0.5% levobupivacaine or 0.75% ropivacaine 5-8ml before surgery.
Interventions/Control_2 - The participants in the control group receive no treatments.
Eligibility:
Age-lower limit - 16
years-old
=
Gender - Male and Female
Key inclusion criteria - The patients aged 16 to 50 who are scheduled to undergo two-jaw orthognathic surgery by the oral and maxillofacial surgeon in our institution.
Key exclusion criteria - The patients who refuse to participate, have a psychiatric disorder, and contraindicate maxillary nerve block.
Target Size - 20
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2026 Year 03 Month 11 Day
Date of IRB - 2026 Year 03 Month 11 Day
Anticipated trial start date - 2026 Year 04 Month 01 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070581
Disclaimer: Curated by HT Syndication.
